UVM Cancer Center rolling out innovative new blood cancer treatment

Vermont Public

An innovative cancer treatment that uses a patient’s own immune system to attack the disease is now available for patients in Vermont and northern New York for the first time.

CAR T-cell therapy was approved in 2017 for a variety of blood cancers, and has led to encouraging results for patients.

Dr. James Gerson was among the first physicians in the country to use the treatment in a clinical setting, at the University of Pennsylvania.

He’s now at the University of Vermont Cancer Center, which just began its own CAR T-cell therapy program. And he joined Vermont Public’s Mary Williams Engisch to talk about the treatment. Their conversation below has been edited and condensed for clarity.

Listen

Previous
Previous

Helping Vermonters and their loved ones cope with Alzheimer's and dementia

Next
Next

Vermont's Emergency Medical Services System Is Struggling to Survive. Can It Be Saved?